Limes Schlosskliniken AG
XETRA:LIK
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
280
388
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Limes Schlosskliniken AG
Limes Schlosskliniken AG
Cost of Revenue
Limes Schlosskliniken AG
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Limes Schlosskliniken AG
XETRA:LIK
|
Cost of Revenue
-€1.2m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Rhoen Klinikum AG
XETRA:RHK
|
Cost of Revenue
-€530.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
0%
|
|
|
M1 Kliniken AG
XETRA:M12
|
Cost of Revenue
-€275.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
|
Mediclin AG
XETRA:MED
|
Cost of Revenue
-€129.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-2%
|
|
|
MATERNUS-Kliniken-AG
XETRA:MAK
|
Cost of Revenue
-€21.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-1%
|
|
|
M
|
MedNation AG
SWB:EIF
|
Cost of Revenue
-€7.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
Limes Schlosskliniken AG
Glance View
Limes Schlosskliniken AG engages in the operation of clinics and healthcare facilities. The company is headquartered in Cologne, Nordrhein-Westfalen and currently employs 138 full-time employees. The company went IPO on 2019-03-18. The firm was founded in September 2015 and is located in Cologne, Germany.
See Also
What is Limes Schlosskliniken AG's Cost of Revenue?
Cost of Revenue
-1.2m
EUR
Based on the financial report for Dec 31, 2022, Limes Schlosskliniken AG's Cost of Revenue amounts to -1.2m EUR.
What is Limes Schlosskliniken AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-29%
Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for Limes Schlosskliniken AG have been -46% over the past three years , -29% over the past five years .
You don't have any saved screeners yet
